- Home
- AXSM vs BCO Comparison
AXSM vs BCO Comparison
Compare AXSM & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BCO
- Stock Information
- Founded
- AXSM 2012
- BCO 1859
- Country
- AXSM United States
- BCO United States
- Employees
- AXSM N/A
- BCO N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BCO Oil Refining/Marketing
- Sector
- AXSM Health Care
- BCO Consumer Discretionary
- Exchange
- AXSM Nasdaq
- BCO Nasdaq
- Market Cap
- AXSM 4.5B
- BCO 5.0B
- IPO Year
- AXSM 2015
- BCO N/A
- Fundamental
- Price
- AXSM $90.83
- BCO $109.95
- Analyst Decision
- AXSM Strong Buy
- BCO Strong Buy
- Analyst Count
- AXSM 14
- BCO 3
- Target Price
- AXSM $124.57
- BCO $123.50
- AVG Volume (30 Days)
- AXSM 422.8K
- BCO 294.0K
- Earning Date
- AXSM 11-04-2024
- BCO 11-05-2024
- Dividend Yield
- AXSM N/A
- BCO 0.88%
- EPS Growth
- AXSM N/A
- BCO 26.91
- EPS
- AXSM N/A
- BCO 2.97
- Revenue
- AXSM $291,489,000.00
- BCO $4,962,200,000.00
- Revenue This Year
- AXSM $42.50
- BCO $5.22
- Revenue Next Year
- AXSM $69.28
- BCO $4.91
- P/E Ratio
- AXSM N/A
- BCO $37.01
- Revenue Growth
- AXSM 59.73
- BCO 4.93
- 52 Week Low
- AXSM $55.02
- BCO $64.15
- 52 Week High
- AXSM $98.40
- BCO $115.91
- Technical
- Relative Strength Index (RSI)
- AXSM 57.49
- BCO 49.74
- Support Level
- AXSM $88.02
- BCO $107.90
- Resistance Level
- AXSM $91.30
- BCO $115.91
- Average True Range (ATR)
- AXSM 3.18
- BCO 2.52
- MACD
- AXSM -0.35
- BCO -0.26
- Stochastic Oscillator
- AXSM 60.07
- BCO 25.59
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BCO Brinks Company (The)
The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.